<DOC>
	<DOCNO>NCT00144261</DOCNO>
	<brief_summary>1 . In order obtain insight NVP affect HDL metabolism , vivo kinetics HDL apolipoprotein , Apo A-1 , 6 week initiation NVP contain treatment evaluate . In addition , activity key enzymes related HDL metabolism assess . [ Designated safety issue : No ] 2 . In order determine relevance HDL increase decrease cardiovascular risk HIV-positive subject evaluate endothelial function ( FMD ) surrogate marker cardiovascular disease patient . [ Designated safety issue : No ]</brief_summary>
	<brief_title>An Open-label , Non-randomized , Single-arm Study Investigate Mechanism ( ) Which Nevirapine Increases Plasma HDL HIV+ Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Patients include meet follow criterion : 1 . 18 year age old . 2 . Ability willingness provide sign dated write informed consent prior admission study accordance GCP local legislation . 3 . Patients stable therapy Trizivir ( equivalent component drug ) , least 6 month prior screen . 4 . Patients plasma HIV1RNA &lt; =50 copies/mL document least two occasion within 6 month prior enrollment . 5 . Documentation plasma HIV1 RNA &lt; =50 copies/mL &gt; =6 month Trizivir without antiretroviral agent . Documentation include date result viral load test previous six month . 6 . Ability willingness complete study . Patients include meet one follow criterion : 1 . Previous exposure NNRTI drug . 2 . Documented diabetes mellitus . 3 . Documented hypertension ( systolic &gt; 155 mmHg and/or diastolic &gt; 95 mmHg ) . 4 . Fasting hypertriglyceridemia ( &gt; 5.6 mmol/L 500 mg/dl ) . 5 . Use lipidlowering medication 90 day prior study enrollment . 6 . Chronic active hepatitis B and/or C infection history . 7 . Anemia ( Hb &lt; 7.0 mmol/l 11 g/dl hematocrit &lt; 32 % ) . 8 . Active opportunistic infection neoplasm within 3 month prior screen visit exception cutaneous Kaposi 's sarcoma without evidence progressive disease . 9 . Any history cardiovascular disease ( infarction , heart failure , peripheral vascular disease , cerebrovascular disease ) . 10 . Hepatic , renal thyroid abnormality , determine significant Principal Investigator . 11 . Pregnancy lactation . 12 . Active anticoagulation therapy ( coumarin derivates , heparin ) . 13 . History HIV2 infection . 14 . Female patient CD4 count &gt; 250 cells/mm3 . 15 . Male patient CD4 count &gt; 400 cells/mm3 . Others list .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>